Infliximab for Idiopathic Deep Cutaneous Vasculitis Refractory to Cyclophosphamide. (15th June 2010)

• Record Type: Journal Article
• Authors: Schafranski, Marcelo Derbli; Campanari, Giuliano Doretto
• Other Names: Minar Erich Academic Editor.
• Is Part Of: International journal of vascular medicine. Volume 2010(2010)
• Publication Date: 2010-06-15
• Subjects: Blood-vessels -- Diseases -- Periodicals; 616.13005
• DOI: 10.1155/2010/951850
• Languages: English
• ISSNs: 2090-2824

Abstract

Abstract : Cutaneous vasculitis can be classified as primary or idiopathic; or secondary, when it presents as a manifestation of connective tissue diseases, infections, drug reactions or malignancies. Although most of the idiopathic cases are self-limited and responsive to supportive measures and nonsteroidal anti-inflammatory drugs, potent immunosuppressants are sometimes required for the management of the refractory situations. Here we describe a case of a 32-year-old Caucasian female patient with history of idiopathic cutaneous deep vasculitis unresponsive to methotrexate, dapsone, and cyclophosphamide who was effectively treated with infliximab.